1220 ET - Ashland is in a better position after a restructuring process that involved divesting two of its business divisions, BMO analyst John McNulty wrote in a note. The additives and specialty ingredients company "has largely cleaned up its portfolio and is firmly focused on improving costs while continuing to drive its innovation pillars (for longer-term growth) where we have seen encouraging signs," McNulty wrote. The presence of activist Standard Investments, which earlier this month disclosed a 5.7% stake in the company, will also push management to focus more on execution and value creation, McNulty wrote. BMO upgraded the stock to "outperform" and raised the price target to $71, from $59.15. (elias.schisgall@wsj.com)
(END) Dow Jones Newswires
December 15, 2025 12:20 ET (17:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.